Rosiello Robert L. 4
4 · Seres Therapeutics, Inc. · Filed Aug 6, 2025
Insider Transaction Report
Form 4
Rosiello Robert L.
Director
Transactions
- Award
Stock Option (right to buy)
2025-08-05+10,000→ 10,000 totalExercise: $14.28Exp: 2035-08-05→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in four equal quarterly installments occurring on August 5, 2026, August 5, 2027, August 5, 2028, August 5, 2029, subject to the reporting person continuing in service on the Board as a non-employee director through the applicable vesting date.